Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06555315 · ClinicalTrials.gov registry record · NA
Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)
A NA study of Premature Infants and Very Low Birth Weight Infant, sponsored by CHRISTUS Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06555315: Recruiting NA study of Premature Infants and Very Low Birth Weight Infant, sponsored by CHRISTUS Health.
NCT06555315 is a NA study of Premature Infants and Very Low Birth Weight Infant that is actively recruiting participants, run by CHRISTUS Health. The registered enrollment target is 100 participants, below the 232-participant average among 4 other Premature Infants trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06555315, a NA study of Premature Infants and Very Low Birth Weight Infant, is actively recruiting participants, sponsored by CHRISTUS Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age in premature neonates
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT 6 mg/kg of oral iron as ferrous sulfate administered every other day.
- DIETARY_SUPPLEMENT 6 mg/kg of oral iron as ferrous sulfate administered every day.
Study Locations (1)
Texas
- CHRISTUS Children's - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2026-03-28 |
| Phase | NA |
What NCT06555315 shows while recruiting
NCT06555315 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 232-participant average among 4 other Premature Infants trials with a reported enrollment target (57% lower).
The record links to 5 conditions, with Premature Infants appearing as the primary indexed condition, and to 2 interventions - of which 6 mg/kg of oral iron as ferrous sulfate administered every other day. is the first listed.
NCT06555315 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06555315 about?
NCT06555315 is a clinical study titled "Pilot Trial Investigating Every Other Day Dosing of Oral Iron in Premature Infants (IQONic)". Study focuses on determining if daily versus every-other-day (EOD) oral iron at the same dose per kilogram per day will achieve similar incidence of iron replete status at 36 weeks post-menstrual age in premature neonates
What is the current status of trial NCT06555315?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2024-08-01. Estimated completion is 2026-03-28.
What conditions does trial NCT06555315 study?
This clinical trial studies the following conditions: Premature Infants, Very Low Birth Weight Infant, Anemia of Prematurity, Iron Deficiency, Anaemia in Children, Extremely Low Birth Weight.
What interventions are being tested in trial NCT06555315?
The interventions under investigation include: 6 mg/kg of oral iron as ferrous sulfate administered every other day. (DIETARY_SUPPLEMENT), 6 mg/kg of oral iron as ferrous sulfate administered every day. (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06555315?
This trial is sponsored by CHRISTUS Health, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06555315 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Infants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI